Advertisement

Table of Contents

October 29, 2015; 126 (18)

INSIDE BLOOD COMMENTARIES

BLOOD SPOTLIGHT

CLINICAL TRIALS AND OBSERVATIONS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

  • Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
    Romain Guièze, Pauline Robbe, Ruth Clifford, Sophie de Guibert, Bruno Pereira, Adele Timbs, Marie-Sarah Dilhuydy, Maite Cabes, Loïc Ysebaert, Adam Burns, Florence Nguyen-Khac, Frédéric Davi, Lauren Véronèse, Patricia Combes, Magali Le Garff-Tavernier, Véronique Leblond, Hélène Merle-Béral, Reem Alsolami, Angela Hamblin, Joanne Mason, Andrew Pettitt, Peter Hillmen, Jenny Taylor, Samantha J. L. Knight, Olivier Tournilhac and Anna Schuh
  • Cell of origin of transformed follicular lymphoma
    Robert Kridel, Anja Mottok, Pedro Farinha, Susana Ben-Neriah, Daisuke Ennishi, Yvonne Zheng, Elizabeth A. Chavez, Hennady P. Shulha, King Tan, Fong Chun Chan, Merrill Boyle, Barbara Meissner, Adele Telenius, Laurie H. Sehn, Marco A. Marra, Sohrab P. Shah, Christian Steidl, Joseph M. Connors, David W. Scott and Randy D. Gascoyne

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

PLATELETS AND THROMBOPOIESIS

TRANSFUSION MEDICINE

BLOOD WORK

CORRESPONDENCE